OVERVIEW OF THE MARKET OF SLEEP NORMALIZING PRODUCTS IN THE RETAIL COMMERCIAL SECTOR OF THE PHARMACEUTICAL MARKET, BASED ON THE RESULTS OF 2016

Despite the prevalence of sleep problems (28 to 45% of the population), the sleep normalizing drugs are difficult to access. The access is restricted mainly because most of them are only available on prescription. Some brands are on strict record keeping in pharmacies, as controlled substances. By the results of 2016, the sales of the sleeping pills reached 1.94 billion rubles (5.24 million packages), whereas the sales of the group of other sleep improving products were 6 times more in value (12.91 billion rubles) and almost 40 times more in packages (199,14 billion packages).

 Trends in sale of sleep improving medicinal products and rating of the hypnotic drugs brands in retail commercial sector of the pharmaceutical market, 2014 to 2016

* The retail sales from pharmacies are presented in sell-out prices.

 Source: AlphaRM – Monitoring of retail sales of medicinal products and dietary supplements in Russian Federation.

Загрузить

The reproduction of materials is allowed only if the limitations established by the Rightholder are observed, with mention of the author of the materials used and the reference to ALPHARM LLC as a source, with a mandatory hyperlink to www.alpharm.ru website.